Skip to main content

Table 3 Antibiotic susceptibility by country

From: An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance

Antibiotic class France Germany Italy Spain United States
Aminoglycosides 141(76.6) 120 (58.3) 101 (75.2) 112 (58.9) 257 (80.2)
Antipseudomonal carbapenems 139 (60.4) 119 (52.1) 107 (57.9) 112 (47.3) 257 (79.0)
Antipseudomonal cephalosporins 140 (77.1) 120 (60.8) 101 (74.3) 111 (59.5) 258 (81.4)
Antipseudomonal fluoroquinolones 138 (66.7) 118 (61.0) 100 (75.0) 111 (52.3) 257 (75.9)
Antipseudomonal penicillins + 141 (64.5) 118 (46.5) 108 (70.3) 110 (63.6) 253 (82.6)
β-lactamase inhibitors
Multidrug-resistant 141 (33.3) 120 (44.2) 108 (22.2) 113 (43.4) 258 (20.5)
Extensively drug-resistant 141 (17.7) 120 (34.2) 108 (2.8) 113 (13.3) 258 (3.5)
  1. Data presented as number of isolates tested (% susceptible). Multidrug-resistant: non-susceptible to one or more agents in three or more antibiotic classes. Extensively drug-resistant: non-susceptible to one or more agents in all but two or fewer antibiotic classes.